FI861125A0 - Vid vaord av diabeteskomplikationer tillaempade spiroimidazoler. - Google Patents
Vid vaord av diabeteskomplikationer tillaempade spiroimidazoler.Info
- Publication number
- FI861125A0 FI861125A0 FI861125A FI861125A FI861125A0 FI 861125 A0 FI861125 A0 FI 861125A0 FI 861125 A FI861125 A FI 861125A FI 861125 A FI861125 A FI 861125A FI 861125 A0 FI861125 A0 FI 861125A0
- Authority
- FI
- Finland
- Prior art keywords
- pct
- vaord
- tillaempade
- spiroimidazoler
- diabeteskomplikationer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8401155 | 1984-07-20 | ||
| PCT/US1984/001155 WO1986000807A1 (en) | 1984-07-20 | 1984-07-20 | Spiro-imidazolones for treatment of diabetes complications |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI861125A0 true FI861125A0 (fi) | 1986-03-18 |
| FI861125A FI861125A (fi) | 1986-03-18 |
| FI80037B FI80037B (fi) | 1989-12-29 |
| FI80037C FI80037C (fi) | 1990-04-10 |
Family
ID=22182207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI861125A FI80037C (fi) | 1984-07-20 | 1986-03-18 | Foerfarande av framstaellning av nya terapeutiskt anvaendbara spiro/benso/b/tiofen-7(6h), 4'-imidazolidin/-2',5'-dionderivat. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4680306A (fi) |
| EP (1) | EP0171213B1 (fi) |
| KR (1) | KR870000626B1 (fi) |
| AT (1) | ATE37372T1 (fi) |
| AU (1) | AU553719B2 (fi) |
| CA (1) | CA1246085A (fi) |
| DE (1) | DE3565106D1 (fi) |
| DK (1) | DK329485A (fi) |
| EG (1) | EG17281A (fi) |
| ES (1) | ES8604594A1 (fi) |
| FI (1) | FI80037C (fi) |
| GR (1) | GR851763B (fi) |
| HU (1) | HU198212B (fi) |
| IL (1) | IL75801A (fi) |
| PH (1) | PH21886A (fi) |
| PL (1) | PL145598B1 (fi) |
| PT (1) | PT80829B (fi) |
| WO (1) | WO1986000807A1 (fi) |
| ZA (1) | ZA855460B (fi) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3501B1 (ar) * | 2014-12-22 | 2020-07-05 | Servier Lab | مشتقات 5-{(بيبرازين - 1-يل)-3-أوكسو - بروبيل}- إيميدازوليدين-2، 4 - دايون كمثبطات ل adamts لمعالجة هشاشة العظام) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3985888A (en) * | 1969-07-24 | 1976-10-12 | Richardson-Merrell Inc. | Methods of inducing sedation using certain spiroalkanone-imides |
| US3821383A (en) * | 1972-07-10 | 1974-06-28 | Ayerst Mckenna & Harrison | Compositions for and a method of treating diabetic complications |
| US4117230A (en) * | 1976-10-18 | 1978-09-26 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
| US4130714A (en) * | 1977-05-23 | 1978-12-19 | Pfizer Inc. | Hydantoin therapeutic agents |
| US4127665A (en) * | 1978-01-18 | 1978-11-28 | Pfizer Inc. | Thienohydantoin derivatives |
| US4147797A (en) * | 1978-08-11 | 1979-04-03 | Pfizer Inc. | Spiro-furanohydantoin derivatives |
| US4248882A (en) * | 1980-02-12 | 1981-02-03 | Pfizer Inc. | Treating diabetes-associated complications with hydantoin amines |
| IE52879B1 (en) * | 1981-05-12 | 1988-03-30 | Ici Plc | Pharmaceutical spiro-hydantoin derivatives |
| EP0065392B1 (en) * | 1981-05-13 | 1985-02-13 | Imperial Chemical Industries Plc | Pharmaceutical compositions containing spiro succinimide derivatives |
| US4575507A (en) * | 1985-05-29 | 1986-03-11 | Pfizer Inc. | Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use |
-
1984
- 1984-07-20 US US06/842,109 patent/US4680306A/en not_active Expired - Lifetime
- 1984-07-20 WO PCT/US1984/001155 patent/WO1986000807A1/en active IP Right Grant
- 1984-07-20 HU HU843235A patent/HU198212B/hu not_active IP Right Cessation
-
1985
- 1985-06-27 CA CA000485492A patent/CA1246085A/en not_active Expired
- 1985-07-15 IL IL75801A patent/IL75801A/xx unknown
- 1985-07-16 GR GR851763A patent/GR851763B/el unknown
- 1985-07-18 DE DE8585305115T patent/DE3565106D1/de not_active Expired
- 1985-07-18 ES ES545353A patent/ES8604594A1/es not_active Expired
- 1985-07-18 EP EP85305115A patent/EP0171213B1/en not_active Expired
- 1985-07-18 KR KR1019850005114A patent/KR870000626B1/ko not_active IP Right Cessation
- 1985-07-18 EG EG428/85A patent/EG17281A/xx active
- 1985-07-18 AT AT85305115T patent/ATE37372T1/de active
- 1985-07-18 PH PH32539A patent/PH21886A/en unknown
- 1985-07-18 PL PL1985254593A patent/PL145598B1/pl unknown
- 1985-07-18 PT PT80829A patent/PT80829B/pt not_active IP Right Cessation
- 1985-07-19 AU AU45189/85A patent/AU553719B2/en not_active Ceased
- 1985-07-19 DK DK329485A patent/DK329485A/da not_active Application Discontinuation
- 1985-07-19 ZA ZA855460A patent/ZA855460B/xx unknown
-
1986
- 1986-03-18 FI FI861125A patent/FI80037C/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK329485D0 (da) | 1985-07-19 |
| DE3565106D1 (en) | 1988-10-27 |
| PT80829B (pt) | 1987-11-30 |
| PL145598B1 (en) | 1988-10-31 |
| ES545353A0 (es) | 1986-02-01 |
| FI861125A (fi) | 1986-03-18 |
| KR870000626B1 (ko) | 1987-03-26 |
| ATE37372T1 (de) | 1988-10-15 |
| EP0171213B1 (en) | 1988-09-21 |
| DK329485A (da) | 1986-01-21 |
| WO1986000807A1 (en) | 1986-02-13 |
| PH21886A (en) | 1988-03-25 |
| KR860001114A (ko) | 1986-02-22 |
| AU553719B2 (en) | 1986-07-24 |
| ES8604594A1 (es) | 1986-02-01 |
| EG17281A (en) | 1989-06-30 |
| HUT39087A (en) | 1986-08-28 |
| HU198212B (en) | 1989-08-28 |
| FI80037C (fi) | 1990-04-10 |
| IL75801A0 (en) | 1985-11-29 |
| IL75801A (en) | 1988-09-30 |
| FI80037B (fi) | 1989-12-29 |
| EP0171213A1 (en) | 1986-02-12 |
| PT80829A (en) | 1985-08-01 |
| US4680306A (en) | 1987-07-14 |
| GR851763B (fi) | 1985-11-26 |
| CA1246085A (en) | 1988-12-06 |
| AU4518985A (en) | 1986-01-23 |
| PL254593A1 (en) | 1986-06-17 |
| ZA855460B (en) | 1987-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES483511A1 (es) | Un procedimiento para la preparaion de nuevas espiro-oxazo- lidinohoinas. | |
| DK0581959T3 (da) | Anvendelse af makrolidforbindelser til øjensygdomme | |
| FI890311A (fi) | Kemiska foereningar. | |
| GR861803B (en) | Novel carbonic acid derivatives method for their preparation their use and medicine containing them | |
| ZA886097B (en) | Pharmaceutical composition for the treatment of psoriasis | |
| ATE157010T1 (de) | Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen | |
| FI861125A (fi) | Vid vaord av diabeteskomplikationer tillaempade spiroimidazoler. | |
| IE832854L (en) | Spiro-3-hetero-azolones for treatment of diabetic¹complications. | |
| ATE30585T1 (de) | Spirosuccinimide und ihre anwendung in der behandlung von zuckerkrankheitskomplikationen. | |
| DE3162277D1 (en) | N-(4-phenyl-2-thiazolyl)-oxamidic-acid-2-ethoxyethylester, process for its preparation and pharmaceutical compositions containing this compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: PFIZER INC. |